STOK Stoke Therapeutics | $11.68
+3.4% | 12/20/2024 | Initiated by | Chardan Capital | - | Buy | $24.00 | N/A | View details for Chardan Capital rating of Stoke Therapeutics (NASDAQ:STOK) on 12/20/2024 |
PRTA Prothena | $15.22
-4.9% | 12/20/2024 | Initiated by | Chardan Capital | - | Buy | $40.00 | N/A | View details for Chardan Capital rating of Prothena (NASDAQ:PRTA) on 12/20/2024 |
MNMD Mind Medicine (MindMed) | $7.16
+2.1% | 12/20/2024 | Initiated by | Chardan Capital | - | Buy | $20.00 | N/A | View details for Chardan Capital rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 12/20/2024 |
CGTX Cognition Therapeutics | $0.63
-0.6% | 12/19/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 12/19/2024 |
KRYS Krystal Biotech | $164.83
+2.5% | 12/18/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $212.00 -> $212.00 | N/A | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 12/18/2024 |
TNYA Tenaya Therapeutics | $1.67
+18.4% | 12/18/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 12/18/2024 |
|
INOD Innodata | $43.01
+8.2% | 12/13/2024 | Reiterated by | Chardan Capital | - | Buy | $45.00 | N/A | View details for Chardan Capital rating of Innodata (NASDAQ:INOD) on 12/13/2024 |
EDIT Editas Medicine | $1.31
-2.2% | 12/13/2024 | Reiterated by | Chardan Capital | Analyst Y. Livshits | Buy -> Neutral | | N/A | View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 12/13/2024 |
KRYS Krystal Biotech | $164.83
+2.5% | 12/12/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $212.00 -> $212.00 | N/A | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 12/12/2024 |
ARWR Arrowhead Pharmaceuticals | $19.45
-0.3% | 12/12/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $60.00 -> $60.00 | N/A | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 12/12/2024 |
PRQR ProQR Therapeutics | $2.63
+1.5% | 12/12/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 12/12/2024 |
CRVO CervoMed | $2.23
| 12/11/2024 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy -> Neutral | | N/A | View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 12/11/2024 |
SLN Silence Therapeutics | $6.88
+8.5% | 12/10/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $55.00 -> $55.00 | N/A | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 12/10/2024 |
CRSP CRISPR Therapeutics | $40.72
+0.8% | 12/10/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $94.00 -> $94.00 | N/A | View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 12/10/2024 |
FBRX Forte Biosciences | $19.34
+3.6% | 12/4/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $64.00 -> $64.00 | N/A | View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 12/4/2024 |
SNTI Senti Biosciences | $3.97
-0.3% | 12/2/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 12/2/2024 |
OTLK Outlook Therapeutics | $1.44
+3.6% | 12/2/2024 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy -> Neutral | | N/A | View details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 12/2/2024 |
ARWR Arrowhead Pharmaceuticals | $19.45
-0.3% | 11/27/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $60.00 -> $60.00 | N/A | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 11/27/2024 |
MGX Metagenomi | $4.05
+4.9% | 11/20/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 11/20/2024 |
IMRX Immuneering | $2.00
+8.7% | 11/20/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $13.00 -> $13.00 | N/A | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 11/20/2024 |
RGNX REGENXBIO | $7.62
+2.8% | 11/20/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $52.00 -> $52.00 | N/A | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 11/20/2024 |
ABUS Arbutus Biopharma | $3.21
| 11/20/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.50 -> $5.00 | N/A | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 11/20/2024 |
RCKT Rocket Pharmaceuticals | $11.56
+1.9% | 11/18/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $62.00 -> $62.00 | N/A | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 11/18/2024 |
OCGN Ocugen | $0.77
+0.3% | 11/18/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $6.00 -> $6.00 | N/A | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 11/18/2024 |
MGTX MeiraGTx | $6.15
+5.3% | 11/18/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $36.00 -> $36.00 | N/A | View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 11/18/2024 |
NTLA Intellia Therapeutics | $12.18
+0.8% | 11/18/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $88.00 -> $91.00 | N/A | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/18/2024 |
FBRX Forte Biosciences | $19.34
+3.6% | 11/15/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $3.00 -> $64.00 | N/A | View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 11/15/2024 |
CGTX Cognition Therapeutics | $0.63
-0.6% | 11/15/2024 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 11/15/2024 |
CLSD Clearside Biomedical | $0.87
-6.2% | 11/15/2024 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy -> Buy | $6.00 -> $6.00 | N/A | View details for Chardan Capital rating of Clearside Biomedical (NASDAQ:CLSD) on 11/15/2024 |
CRVO CervoMed | $2.23
| 11/14/2024 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy -> Buy | $55.00 -> $55.00 | N/A | View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 11/14/2024 |
TSHA Taysha Gene Therapies | $1.85
| 11/14/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 11/14/2024 |
PASG Passage Bio | $0.66
+0.9% | 11/14/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 11/14/2024 |
FDMT 4D Molecular Therapeutics | $6.31
+9.2% | 11/14/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $39.00 -> $39.00 | N/A | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 11/14/2024 |
SLN Silence Therapeutics | $6.88
+8.5% | 11/14/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $55.00 -> $55.00 | N/A | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 11/14/2024 |
ALUR Allurion Technologies | $0.35
+24.3% | 11/14/2024 | Downgraded by | Chardan Capital | Analyst K. Nakae | Buy -> Neutral | | N/A | View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 11/14/2024 |
MCRB Seres Therapeutics | $0.92
-0.6% | 11/13/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $1.25 -> $1.25 | N/A | View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 11/13/2024 |
RNA Avidity Biosciences | $31.82
+2.5% | 11/13/2024 | Reiterated by | Chardan Capital | Analyst K. Nakae | Buy -> Buy | $65.00 -> $65.00 | N/A | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 11/13/2024 |
DYN Dyne Therapeutics | $23.99
-1.3% | 11/13/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $50.00 -> $50.00 | N/A | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 11/13/2024 |
OBIO Orchestra BioMed | $4.92
+2.5% | 11/13/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 11/13/2024 |
PRME Prime Medicine | $2.90
+3.9% | 11/13/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $17.00 -> $15.00 | N/A | View details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 11/13/2024 |
Combine the QQQ, IWM and SPY in one trade (Ad) If you’ve been investing in the major indexes for the last 20 years, you may need a new strategy.
Because the Dow Jones has returned just 349%...
The Russell 2000 has returned just 397%...
And the S&P 500 has returned just 450%.
And although I can’t guarantee results or against losses…
I want to tell you about my “2-Click Trade” that has encapsulated more than the return of ALL THREE OF THOSE INDEXES COMBINED…
Plus, it targets multiple overnight payouts in a month with 84.3% accuracy!
While I cannot promise future returns or against losses… You can find out about this “2-Click Trade” here. |
FEMY Femasys | $1.09
-0.9% | 11/13/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $10.00 -> $8.00 | N/A | View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 11/13/2024 |
CRGX CARGO Therapeutics | $14.90
+10.3% | 11/13/2024 | Reiterated by | Chardan Capital | Analyst G. Livshits | Buy -> Buy | $28.00 -> $28.00 | N/A | View details for Chardan Capital rating of CARGO Therapeutics (NASDAQ:CRGX) on 11/13/2024 |
LXEO Lexeo Therapeutics | $6.28
+4.0% | 11/13/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $23.00 -> $25.00 | N/A | View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 11/13/2024 |
SLDB Solid Biosciences | $4.16
+3.7% | 11/11/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for Chardan Capital rating of Solid Biosciences (NASDAQ:SLDB) on 11/11/2024 |
RCKT Rocket Pharmaceuticals | $11.56
+1.9% | 11/11/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $62.00 -> $62.00 | N/A | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 11/11/2024 |
ZURA Zura Bio | $2.28
-2.6% | 11/8/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $14.00 -> $12.00 | N/A | View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 11/8/2024 |
OCGN Ocugen | $0.77
+0.3% | 11/8/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $6.00 -> $6.00 | N/A | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 11/8/2024 |
EYPT EyePoint Pharmaceuticals | $7.10
-0.3% | 11/8/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $28.00 -> $33.00 | N/A | View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 11/8/2024 |
SABS SAB Biotherapeutics | $4.65
+19.2% | 11/7/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 11/7/2024 |
TNYA Tenaya Therapeutics | $1.67
+18.4% | 11/7/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $20.00 -> $18.00 | N/A | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 11/7/2024 |
COYA Coya Therapeutics | $5.24
+1.6% | 11/7/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 11/7/2024 |
IPSC Century Therapeutics | $1.10
+4.8% | 11/7/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $17.00 -> $11.00 | N/A | View details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 11/7/2024 |
ABUS Arbutus Biopharma | $3.21
| 11/6/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $4.00 -> $4.50 | N/A | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 11/6/2024 |
EDIT Editas Medicine | $1.31
-2.2% | 11/5/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $12.00 -> $12.00 | Low | View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 11/5/2024 |
ALNY Alnylam Pharmaceuticals | $245.44
+2.8% | 11/1/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $300.00 -> $300.00 | High | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 11/1/2024 |
CGTX Cognition Therapeutics | $0.63
-0.6% | 10/31/2024 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy -> Buy | $11.00 -> $11.00 | Low | View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 10/31/2024 |
COYA Coya Therapeutics | $5.24
+1.6% | 10/30/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $14.00 -> $14.00 | High | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 10/30/2024 |
RNA Avidity Biosciences | $31.82
+2.5% | 10/30/2024 | Target Raised by | Chardan Capital | Analyst K. Nakae | Buy -> Buy | $60.00 -> $65.00 | High | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 10/30/2024 |
EYPT EyePoint Pharmaceuticals | $7.10
-0.3% | 10/29/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $28.00 -> $28.00 | Low | View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 10/29/2024 |
LXEO Lexeo Therapeutics | $6.28
+4.0% | 10/25/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $23.00 -> $23.00 | Low | View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 10/25/2024 |
NTLA Intellia Therapeutics | $12.18
+0.8% | 10/24/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $94.00 -> $88.00 | Low | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 10/24/2024 |
EDIT Editas Medicine | $1.31
-2.2% | 10/22/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $20.00 -> $12.00 | Medium | View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 10/22/2024 |
RGNX REGENXBIO | $7.62
+2.8% | 10/22/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $52.00 -> $52.00 | High | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 10/22/2024 |
CLSD Clearside Biomedical | $0.87
-6.2% | 10/14/2024 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy -> Buy | $6.00 -> $6.00 | Low | View details for Chardan Capital rating of Clearside Biomedical (NASDAQ:CLSD) on 10/14/2024 |
ALNY Alnylam Pharmaceuticals | $245.44
+2.8% | 10/11/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $300.00 -> $300.00 | Low | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 10/11/2024 |
FDMT 4D Molecular Therapeutics | $6.31
+9.2% | 9/19/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $38.00 -> $39.00 | High | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 9/19/2024 |
CRVO CervoMed | $2.23
| 9/18/2024 | Initiated by | Chardan Capital | Analyst D. Gataulin | Buy | $55.00 | Medium | View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 9/18/2024 |
SABS SAB Biotherapeutics | $4.65
+19.2% | 9/9/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $25.00 -> $25.00 | Medium | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 9/9/2024 |
MGX Metagenomi | $4.05
+4.9% | 9/5/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $15.00 -> $15.00 | Low | View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 9/5/2024 |
ALUR Allurion Technologies | $0.35
+24.3% | 8/22/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $5.00 -> $2.50 | Low | View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 8/22/2024 |
CLSD Clearside Biomedical | $0.87
-6.2% | 8/21/2024 | Initiated by | Chardan Capital | Analyst D. Gataulin | Buy | $6.00 | Low | View details for Chardan Capital rating of Clearside Biomedical (NASDAQ:CLSD) on 8/21/2024 |
FBRX Forte Biosciences | $19.34
+3.6% | 8/19/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $3.00 -> $3.00 | Low | View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 8/19/2024 |
MGX Metagenomi | $4.05
+4.9% | 8/19/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $17.00 -> $15.00 | Low | View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 8/19/2024 |
OTLK Outlook Therapeutics | $1.44
+3.6% | 8/16/2024 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy -> Buy | $53.00 -> $53.00 | Low | View details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 8/16/2024 |
SLN Silence Therapeutics | $6.88
+8.5% | 8/16/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $55.00 -> $55.00 | Low | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 8/16/2024 |
FEMY Femasys | $1.09
-0.9% | 8/14/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $12.00 -> $10.00 | Low | View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 8/14/2024 |
LXEO Lexeo Therapeutics | $6.28
+4.0% | 8/14/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $23.00 -> $23.00 | Low | View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 8/14/2024 |
MCRB Seres Therapeutics | $0.92
-0.6% | 8/14/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $1.25 -> $1.25 | Low | View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 8/14/2024 |
TSHA Taysha Gene Therapies | $1.85
| 8/13/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 -> $7.00 | Low | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 8/13/2024 |
SABS SAB Biotherapeutics | $4.65
+19.2% | 8/12/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $25.00 -> $25.00 | Low | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 8/12/2024 |
GANX Gain Therapeutics | $1.56
-0.6% | 8/9/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $6.00 -> $6.00 | Low | View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 8/9/2024 |
RNA Avidity Biosciences | $31.82
+2.5% | 8/9/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $45.00 -> $60.00 | Low | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 8/9/2024 |
OMGA Omega Therapeutics | $0.84
+3.0% | 8/7/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $7.00 -> $6.00 | Low | View details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 8/7/2024 |
IMRX Immuneering | $2.00
+8.7% | 8/7/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $16.00 -> $12.00 | Low | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 8/7/2024 |
CRSP CRISPR Therapeutics | $40.72
+0.8% | 8/6/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $112.00 -> $94.00 | Low | View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 8/6/2024 |
RCKT Rocket Pharmaceuticals | $11.56
+1.9% | 8/6/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $62.00 -> $62.00 | Low | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 8/6/2024 |
KRYS Krystal Biotech | $164.83
+2.5% | 8/5/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $153.00 -> $208.00 | Low | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 8/5/2024 |
PHMMF Pharma Mar | $81.07
| 8/1/2024 | Upgraded by | Chardan Capital | Analyst K. Nakae | Strong-Buy | | Low | View details for Chardan Capital rating of Pharma Mar (OTCMKTS:PHMMF) on 8/1/2024 |
MGTX MeiraGTx | $6.15
+5.3% | 7/31/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $36.00 | Low | View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 7/31/2024 |
ADVM Adverum Biotechnologies | $4.74
+0.9% | 7/18/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $4.00 -> $40.00 | Low | View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 7/18/2024 |
Trump’s Sending THIS Crypto Higher on Purpose (Ad) Discover the coin set to explode before 2025!
Trump could trigger THIS crypto coin…
 YES, I WANT THE #1 CRYPTO NOW |
ARWR Arrowhead Pharmaceuticals | $19.45
-0.3% | 7/17/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $60.00 -> $60.00 | Low | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 7/17/2024 |
FDMT 4D Molecular Therapeutics | $6.31
+9.2% | 7/17/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $38.00 -> $38.00 | Low | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/17/2024 |
LXEO Lexeo Therapeutics | $6.28
+4.0% | 7/15/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $23.00 -> $23.00 | Low | View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 7/15/2024 |
CRGX CARGO Therapeutics | $14.90
+10.3% | 7/8/2024 | Initiated by | Chardan Capital | Analyst G. Livshits | Buy | $28.00 | Low | View details for Chardan Capital rating of CARGO Therapeutics (NASDAQ:CRGX) on 7/8/2024 |
RCKT Rocket Pharmaceuticals | $11.56
+1.9% | 6/28/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $62.00 -> $62.00 | Low | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 6/28/2024 |
SLN Silence Therapeutics | $6.88
+8.5% | 6/28/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $42.00 -> $55.00 | Low | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 6/28/2024 |
EYPT EyePoint Pharmaceuticals | $7.10
-0.3% | 6/28/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $28.00 -> $28.00 | Low | View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 6/28/2024 |
ARWR Arrowhead Pharmaceuticals | $19.45
-0.3% | 6/26/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $60.00 -> $60.00 | Low | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 6/26/2024 |
TSHA Taysha Gene Therapies | $1.85
| 6/18/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 -> $7.00 | Low | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 6/18/2024 |
RNA Avidity Biosciences | $31.82
+2.5% | 6/12/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $33.00 -> $45.00 | Low | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 6/12/2024 |
OBIO Orchestra BioMed | $4.92
+2.5% | 6/12/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $20.00 -> $20.00 | Low | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 6/12/2024 |
OCS Oculis | $16.98
-0.2% | 6/11/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $30.00 -> $30.00 | Low | View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 6/11/2024 |
CGTX Cognition Therapeutics | $0.63
-0.6% | 6/6/2024 | Initiated by | Chardan Capital | Analyst D. Gataulin | Buy | $11.00 | Low | View details for Chardan Capital rating of Cognition Therapeutics (NASDAQ:CGTX) on 6/6/2024 |
COYA Coya Therapeutics | $5.24
+1.6% | 6/5/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $14.00 -> $14.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 6/5/2024 |
ABUS Arbutus Biopharma | $3.21
| 6/5/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 -> $4.00 | Low | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 6/5/2024 |
IBIO iBio | $2.48
+2.5% | 6/3/2024 | Reiterated by | Chardan Capital | Analyst K. Nakae | Buy -> Buy | $5.00 -> $5.00 | Low | View details for Chardan Capital rating of iBio (NYSE:IBIO) on 6/3/2024 |
ARWR Arrowhead Pharmaceuticals | $19.45
-0.3% | 6/3/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $60.00 -> $60.00 | Low | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 6/3/2024 |
NVX NOVONIX | $1.65
+0.6% | 5/30/2024 | Initiated by | Chardan Capital | Analyst B. Dobson | Buy | $4.00 | Low | View details for Chardan Capital rating of NOVONIX (NASDAQ:NVX) on 5/30/2024 |
IBIO iBio | $2.48
+2.5% | 5/28/2024 | Initiated by | Chardan Capital | Analyst K. Nakae | Buy | $5.00 | Low | View details for Chardan Capital rating of iBio (NYSE:IBIO) on 5/28/2024 |
CRGO Freightos | $2.65
+7.3% | 5/23/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $8.00 -> $6.00 | Low | View details for Chardan Capital rating of Freightos (NASDAQ:CRGO) on 5/23/2024 |
SABS SAB Biotherapeutics | $4.65
+19.2% | 5/21/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $25.00 -> $25.00 | Low | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 5/21/2024 |
DYN Dyne Therapeutics | $23.99
-1.3% | 5/21/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $31.00 -> $42.00 | Low | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 5/21/2024 |
BMTX BM Technologies | $4.80
+0.6% | 5/20/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $8.00 -> $8.00 | Low | View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 5/20/2024 |
SLN Silence Therapeutics | $6.88
+8.5% | 5/17/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $42.00 -> $42.00 | Low | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 5/17/2024 |
ALUR Allurion Technologies | $0.35
+24.3% | 5/15/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 -> $5.00 | Low | View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 5/15/2024 |
OCGN Ocugen | $0.77
+0.3% | 5/15/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 -> $5.00 | Low | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 5/15/2024 |
VFS VinFast Auto | $4.22
+2.7% | 5/13/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $13.00 -> $13.00 | Low | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 5/13/2024 |
CLSK CleanSpark | $11.14
+2.1% | 5/13/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $26.00 -> $26.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 5/13/2024 |
RNA Avidity Biosciences | $31.82
+2.5% | 5/10/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $33.00 -> $33.00 | Low | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 5/10/2024 |
PRQR ProQR Therapeutics | $2.63
+1.5% | 5/10/2024 | Reiterated by | Chardan Capital | Analyst K. Nakae | Buy -> Buy | $2.50 -> $2.50 | Low | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 5/10/2024 |
ARWR Arrowhead Pharmaceuticals | $19.45
-0.3% | 5/10/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $60.00 -> $60.00 | Low | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 5/10/2024 |
PET Wag! Group | $0.22
+8.7% | 5/10/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $8.00 -> $8.00 | Low | View details for Chardan Capital rating of Wag! Group (NASDAQ:PET) on 5/10/2024 |
COYA Coya Therapeutics | $5.24
+1.6% | 5/9/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $14.00 -> $14.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 5/9/2024 |
VLN Valens Semiconductor | $1.84
+2.2% | 5/9/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 -> $4.00 | Low | View details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 5/9/2024 |
SLDP Solid Power | $1.30
+15.0% | 5/8/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 -> $5.00 | Low | View details for Chardan Capital rating of Solid Power (NASDAQ:SLDP) on 5/8/2024 |
MCRB Seres Therapeutics | $0.92
-0.6% | 5/8/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $8.00 -> $6.00 | Low | View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 5/8/2024 |
PLBY PLBY Group | $1.65
-1.2% | 5/8/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 -> $4.00 | Low | View details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 5/8/2024 |
MARA MARA | $19.96
-2.0% | 5/8/2024 | Target Lowered by | Chardan Capital | - | Neutral -> Neutral | $30.00 -> $21.00 | Low | View details for Chardan Capital rating of MARA (NASDAQ:MARA) on 5/8/2024 |
CLSK CleanSpark | $11.14
+2.1% | 5/7/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $26.00 -> $26.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 5/7/2024 |
OMGA Omega Therapeutics | $0.84
+3.0% | 5/7/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 -> $7.00 | Low | View details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 5/7/2024 |
EYPT EyePoint Pharmaceuticals | $7.10
-0.3% | 5/7/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $39.00 -> $28.00 | Low | View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 5/7/2024 |
DYN Dyne Therapeutics | $23.99
-1.3% | 5/6/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $31.00 -> $31.00 | Low | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 5/6/2024 |
ABUS Arbutus Biopharma | $3.21
| 5/3/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 -> $4.00 | Low | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 5/3/2024 |
ALNY Alnylam Pharmaceuticals | $245.44
+2.8% | 5/3/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $225.00 -> $225.00 | Low | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 5/3/2024 |
COYA Coya Therapeutics | $5.24
+1.6% | 4/29/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $14.00 -> $14.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 4/29/2024 |
BMTX BM Technologies | $4.80
+0.6% | 4/22/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $8.00 -> $8.00 | Low | View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 4/22/2024 |
OCGN Ocugen | $0.77
+0.3% | 4/22/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $4.00 -> $5.00 | Low | View details for Chardan Capital rating of Ocugen (NASDAQ:OCGN) on 4/22/2024 |
PRME Prime Medicine | $2.90
+3.9% | 4/22/2024 | Initiated by | Chardan Capital | - | Buy | $17.00 | Low | View details for Chardan Capital rating of Prime Medicine (NYSE:PRME) on 4/22/2024 |
LICY Li-Cycle | $1.48
+4.2% | 4/19/2024 | Reiterated by | Chardan Capital | - | Neutral -> Neutral | $6.00 | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 4/19/2024 |
VFS VinFast Auto | $4.22
+2.7% | 4/18/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $13.00 | Low | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 4/18/2024 |
Trump’s Sending THIS Crypto Higher on Purpose (Ad) Discover the coin set to explode before 2025!
Trump could trigger THIS crypto coin…
YES, I WANT THE #1 CRYPTO NOW |
DFLI Dragonfly Energy | $3.12
+5.1% | 4/16/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $27.00 | Low | View details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 4/16/2024 |
SABS SAB Biotherapeutics | $4.65
+19.2% | 4/16/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $25.00 | Low | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/16/2024 |
VFS VinFast Auto | $4.22
+2.7% | 4/10/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $13.00 | Low | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 4/10/2024 |
NRGV Energy Vault | $1.69
+11.9% | 4/8/2024 | Reiterated by | Chardan Capital | - | Buy -> Sell | $7.00 -> $0.75 | Low | View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 4/8/2024 |
ACHL Achilles Therapeutics | $0.98
| 4/5/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $11.00 -> $6.00 | Low | View details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 4/5/2024 |
BMTX BM Technologies | $4.80
+0.6% | 4/4/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $8.00 | Low | View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 4/4/2024 |
ALUR Allurion Technologies | $0.35
+24.3% | 4/4/2024 | Initiated by | Chardan Capital | - | Buy | $5.00 | Low | View details for Chardan Capital rating of Allurion Technologies (NYSE:ALUR) on 4/4/2024 |
OUST Ouster | $11.98
+15.0% | 4/3/2024 | Reiterated by | Chardan Capital | - | Buy -> Neutral | $10.00 | Low | View details for Chardan Capital rating of Ouster (NYSE:OUST) on 4/3/2024 |
SABS SAB Biotherapeutics | $4.65
+19.2% | 4/2/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $3.00 -> $25.00 | Low | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/2/2024 |
FEMY Femasys | $1.09
-0.9% | 4/1/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $12.00 | Low | View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 4/1/2024 |
OMGA Omega Therapeutics | $0.84
+3.0% | 4/1/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $12.00 -> $7.00 | Low | View details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 4/1/2024 |
OBIO Orchestra BioMed | $4.92
+2.5% | 3/28/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $20.00 | Low | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 3/28/2024 |
MGX Metagenomi | $4.05
+4.9% | 3/28/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $21.00 | Low | View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 3/28/2024 |
GANX Gain Therapeutics | $1.56
-0.6% | 3/27/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $6.00 | Low | View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 3/27/2024 |
PLBY PLBY Group | $1.65
-1.2% | 3/26/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 | Low | View details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 3/26/2024 |
TNYA Tenaya Therapeutics | $1.67
+18.4% | 3/21/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $20.00 | Low | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/21/2024 |
FEMY Femasys | $1.09
-0.9% | 3/21/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $12.00 | Low | View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 3/21/2024 |
TSHA Taysha Gene Therapies | $1.85
| 3/21/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $5.00 -> $7.00 | Low | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 3/21/2024 |
COYA Coya Therapeutics | $5.24
+1.6% | 3/20/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $11.00 -> $14.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/20/2024 |
OCS Oculis | $16.98
-0.2% | 3/19/2024 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy -> Buy | $30.00 | Low | View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 3/19/2024 |
ADVM Adverum Biotechnologies | $4.74
+0.9% | 3/19/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 | Low | View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 3/19/2024 |
PRQR ProQR Therapeutics | $2.63
+1.5% | 3/14/2024 | Target Raised by | Chardan Capital | Analyst K. Nakae | Buy -> Buy | $2.00 -> $2.50 | Low | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 3/14/2024 |
SLN Silence Therapeutics | $6.88
+8.5% | 3/14/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $26.00 -> $42.00 | Low | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 3/14/2024 |
IMRX Immuneering | $2.00
+8.7% | 3/15/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $21.00 -> $16.00 | N/A | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 3/15/2024 |
GWH ESS Tech | $4.66
+5.4% | 3/15/2024 | Target Lowered by | Chardan Capital | - | Neutral -> Neutral | $28.50 -> $12.00 | N/A | View details for Chardan Capital rating of ESS Tech (NYSE:GWH) on 3/15/2024 |
NRGV Energy Vault | $1.69
+11.9% | 3/18/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 | Low | View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 3/18/2024 |
DYN Dyne Therapeutics | $23.99
-1.3% | 3/8/2024 | Target Raised by | Chardan Capital | - | Buy | $20.00 -> $31.00 | Low | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 3/8/2024 |
RGNX REGENXBIO | $7.62
+2.8% | 3/7/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $52.00 | Low | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 3/7/2024 |
MCRB Seres Therapeutics | $0.92
-0.6% | 3/6/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $10.00 -> $8.00 | Low | View details for Chardan Capital rating of Seres Therapeutics (NASDAQ:MCRB) on 3/6/2024 |
MGX Metagenomi | $4.05
+4.9% | 3/5/2024 | Initiated by | Chardan Capital | - | Buy | $21.00 | Low | View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 3/5/2024 |
MARA MARA | $19.96
-2.0% | 3/4/2024 | Target Raised by | Chardan Capital | - | Neutral -> Neutral | $26.00 -> $30.00 | Low | View details for Chardan Capital rating of MARA (NASDAQ:MARA) on 3/4/2024 |
CLSK CleanSpark | $11.14
+2.1% | 3/4/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $13.00 -> $26.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 3/4/2024 |
ABUS Arbutus Biopharma | $3.21
| 3/1/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $4.00 | Low | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 3/1/2024 |
RNA Avidity Biosciences | $31.82
+2.5% | 2/29/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $23.00 | Low | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 2/29/2024 |
VFS VinFast Auto | $4.22
+2.7% | 2/28/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $11.00 -> $13.00 | Low | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 2/28/2024 |
SLDP Solid Power | $1.30
+15.0% | 2/28/2024 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 | Low | View details for Chardan Capital rating of Solid Power (NASDAQ:SLDP) on 2/28/2024 |
CRSP CRISPR Therapeutics | $40.72
+0.8% | 2/22/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $110.00 -> $112.00 | Low | View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/22/2024 |
IOVA Iovance Biotherapeutics | $7.38
+2.2% | 2/20/2024 | Target Raised by | Chardan Capital | - | Buy -> Buy | $29.00 -> $34.00 | Low | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 2/20/2024 |
ALNY Alnylam Pharmaceuticals | $245.44
+2.8% | 2/16/2024 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $250.00 -> $225.00 | Low | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/16/2024 |
OTLK Outlook Therapeutics | $1.44
+3.6% | 2/15/2024 | Upgraded by | Chardan Capital | Analyst D. Gataulin | Neutral -> Buy | $60.00 | Low | View details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 2/15/2024 |
SYBX Synlogic | $1.42
+3.5% | 2/9/2024 | Downgraded by | Chardan Capital | Analyst K. Nakae | Buy -> Neutral | | Low | View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 2/9/2024 |
OCS Oculis | $16.98
-0.2% | 12/5/2023 | Initiated by | Chardan Capital | Analyst D. Gataulin | Buy | $30.00 | Low | View details for Chardan Capital rating of Oculis (NASDAQ:OCS) on 12/5/2023 |
LXEO Lexeo Therapeutics | $6.28
+4.0% | 11/28/2023 | Initiated by | Chardan Capital | Analyst G. Livshits | Buy | $23.00 | Low | View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 11/28/2023 |
LICY Li-Cycle | $1.48
+4.2% | 11/16/2023 | Downgraded by | Chardan Capital | - | Buy -> Neutral | | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 11/16/2023 |
PRQR ProQR Therapeutics | $2.63
+1.5% | 11/8/2023 | Upgraded by | Chardan Capital | Analyst K. Nakae | Neutral -> Buy | $2.00 | Low | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 11/8/2023 |
WBX Wallbox | $0.53
+11.0% | 10/19/2023 | Downgraded by | Chardan Capital | - | Buy -> Neutral | $2.25 | Low | View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 10/19/2023 |
VFS VinFast Auto | $4.22
+2.7% | 10/10/2023 | Initiated by | Chardan Capital | - | Buy | | Low | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 10/10/2023 |
VYGR Voyager Therapeutics | $5.75
+1.1% | 9/18/2023 | Reiterated by | Chardan Capital | Analyst G. Livshits | Neutral | | Low | View details for Chardan Capital rating of Voyager Therapeutics (NASDAQ:VYGR) on 9/18/2023 |
OTLK Outlook Therapeutics | $1.44
+3.6% | 8/31/2023 | Downgraded by | Chardan Capital | Analyst D. Gataulin | Buy -> Neutral | | Low | View details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 8/31/2023 |
ZURA Zura Bio | $2.28
-2.6% | 8/17/2023 | Reiterated by | Chardan Capital | Analyst D. Gataulin | Buy | | Low | View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 8/17/2023 |
Could This Tiny Device Help You Make an Extra $30k a Year? (Ad) I believe it’s going to power Elon Musk’s next AI revolution…
A revolution he believes will be worth more than $9 trillion.
That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. |
QURE uniQure | $16.98
+9.8% | 8/17/2023 | Reiterated by | Chardan Capital | Analyst Y. Livshits | Buy | | Low | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 8/17/2023 |
PLBY PLBY Group | $1.65
-1.2% | 8/17/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $5.00 -> $4.00 | Low | View details for Chardan Capital rating of PLBY Group (NASDAQ:PLBY) on 8/17/2023 |
SLN Silence Therapeutics | $6.88
+8.5% | 8/17/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $26.00 | Low | View details for Chardan Capital rating of Silence Therapeutics (NASDAQ:SLN) on 8/17/2023 |
IOVA Iovance Biotherapeutics | $7.38
+2.2% | 8/16/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $29.00 | Low | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 8/16/2023 |
LICY Li-Cycle | $1.48
+4.2% | 8/16/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $64.00 -> $56.00 | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 8/16/2023 |
VLN Valens Semiconductor | $1.84
+2.2% | 8/15/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $9.00 -> $5.00 | Low | View details for Chardan Capital rating of Valens Semiconductor (NYSE:VLN) on 8/15/2023 |
SNTI Senti Biosciences | $3.97
-0.3% | 8/15/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $60.00 | Low | View details for Chardan Capital rating of Senti Biosciences (NASDAQ:SNTI) on 8/15/2023 |
OTLK Outlook Therapeutics | $1.44
+3.6% | 8/15/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $200.00 | Low | View details for Chardan Capital rating of Outlook Therapeutics (NASDAQ:OTLK) on 8/15/2023 |
TSHA Taysha Gene Therapies | $1.85
| 8/15/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 | Low | View details for Chardan Capital rating of Taysha Gene Therapies (NASDAQ:TSHA) on 8/15/2023 |
TNYA Tenaya Therapeutics | $1.67
+18.4% | 8/14/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $23.00 | Low | View details for Chardan Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 8/14/2023 |
GANX Gain Therapeutics | $1.56
-0.6% | 8/14/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $6.00 | Low | View details for Chardan Capital rating of Gain Therapeutics (NASDAQ:GANX) on 8/14/2023 |
SYBX Synlogic | $1.42
+3.5% | 8/11/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $90.00 | Low | View details for Chardan Capital rating of Synlogic (NASDAQ:SYBX) on 8/11/2023 |
CLSK CleanSpark | $11.14
+2.1% | 8/11/2023 | Target Raised by | Chardan Capital | - | Buy -> Buy | $10.00 -> $11.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 8/11/2023 |
MGTX MeiraGTx | $6.15
+5.3% | 8/11/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $41.00 | Low | View details for Chardan Capital rating of MeiraGTx (NASDAQ:MGTX) on 8/11/2023 |
FDMT 4D Molecular Therapeutics | $6.31
+9.2% | 8/11/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $31.00 | Low | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 8/11/2023 |
RCKT Rocket Pharmaceuticals | $11.56
+1.9% | 8/11/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $61.00 | Low | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 8/11/2023 |
FEMY Femasys | $1.09
-0.9% | 8/11/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $10.00 | Low | View details for Chardan Capital rating of Femasys (NASDAQ:FEMY) on 8/11/2023 |
ADVM Adverum Biotechnologies | $4.74
+0.9% | 8/11/2023 | Upgraded by | Chardan Capital | Analyst D. Gataulin | Neutral -> Buy | $20.00 -> $40.00 | Low | View details for Chardan Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 8/11/2023 |
OBIO Orchestra BioMed | $4.92
+2.5% | 8/9/2023 | Reiterated by | Chardan Capital | Analyst K. Nakae | Buy -> Buy | $20.00 | Low | View details for Chardan Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 8/9/2023 |
COYA Coya Therapeutics | $5.24
+1.6% | 8/9/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $11.00 | Low | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 8/9/2023 |
NRGV Energy Vault | $1.69
+11.9% | 8/9/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 | Low | View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 8/9/2023 |
IOVA Iovance Biotherapeutics | $7.38
+2.2% | 8/9/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $29.00 | Low | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 8/9/2023 |
PET Wag! Group | $0.22
+8.7% | 8/10/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $8.00 | N/A | View details for Chardan Capital rating of Wag! Group (NASDAQ:PET) on 8/10/2023 |
SLDP Solid Power | $1.30
+15.0% | 8/10/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $5.00 | N/A | View details for Chardan Capital rating of Solid Power (NASDAQ:SLDP) on 8/10/2023 |
IPSC Century Therapeutics | $1.10
+4.8% | 8/9/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $19.00 -> $17.00 | Low | View details for Chardan Capital rating of Century Therapeutics (NASDAQ:IPSC) on 8/9/2023 |
RNA Avidity Biosciences | $31.82
+2.5% | 8/9/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $27.00 -> $23.00 | Low | View details for Chardan Capital rating of Avidity Biosciences (NASDAQ:RNA) on 8/9/2023 |
ARWR Arrowhead Pharmaceuticals | $19.45
-0.3% | 8/8/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $60.00 | Low | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 8/8/2023 |
ALNY Alnylam Pharmaceuticals | $245.44
+2.8% | 8/8/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $250.00 | Low | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 8/8/2023 |
CRSP CRISPR Therapeutics | $40.72
+0.8% | 8/7/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $123.00 -> $110.00 | Low | View details for Chardan Capital rating of CRISPR Therapeutics (NASDAQ:CRSP) on 8/7/2023 |
KRYS Krystal Biotech | $164.83
+2.5% | 8/7/2023 | Target Raised by | Chardan Capital | - | Buy -> Buy | $148.00 -> $153.00 | Low | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 8/7/2023 |
PASG Passage Bio | $0.66
+0.9% | 8/7/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $11.00 -> $9.00 | Low | View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 8/7/2023 |
MARA MARA | $19.96
-2.0% | 8/7/2023 | Downgraded by | Chardan Capital | - | Buy -> Neutral | $15.00 | Low | View details for Chardan Capital rating of MARA (NASDAQ:MARA) on 8/7/2023 |
NTLA Intellia Therapeutics | $12.18
+0.8% | 8/7/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $107.00 | Low | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 8/7/2023 |
ACHL Achilles Therapeutics | $0.98
| 8/7/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $11.00 | Low | View details for Chardan Capital rating of Achilles Therapeutics (NASDAQ:ACHL) on 8/7/2023 |
IMRX Immuneering | $2.00
+8.7% | 8/7/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $22.00 | Low | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 8/7/2023 |
ABUS Arbutus Biopharma | $3.21
| 8/4/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $6.00 | Low | View details for Chardan Capital rating of Arbutus Biopharma (NASDAQ:ABUS) on 8/4/2023 |
DYN Dyne Therapeutics | $23.99
-1.3% | 8/4/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $20.00 | Low | View details for Chardan Capital rating of Dyne Therapeutics (NASDAQ:DYN) on 8/4/2023 |
OMGA Omega Therapeutics | $0.84
+3.0% | 8/4/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $12.00 | Low | View details for Chardan Capital rating of Omega Therapeutics (NASDAQ:OMGA) on 8/4/2023 |
PRQR ProQR Therapeutics | $2.63
+1.5% | 8/4/2023 | Reiterated by | Chardan Capital | - | Neutral -> Neutral | $2.00 | Low | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 8/4/2023 |
MESO Mesoblast | $14.63
-12.7% | 8/4/2023 | Target Lowered by | Chardan Capital | - | Sell -> Sell | $4.00 -> $3.00 | Low | View details for Chardan Capital rating of Mesoblast (NASDAQ:MESO) on 8/4/2023 |
RGNX REGENXBIO | $7.62
+2.8% | 8/3/2023 | Reiterated by | Chardan Capital | - | Buy | $55.00 | Low | View details for Chardan Capital rating of REGENXBIO (NASDAQ:RGNX) on 8/3/2023 |
EYPT EyePoint Pharmaceuticals | $7.10
-0.3% | 8/3/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $22.00 | Low | View details for Chardan Capital rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 8/3/2023 |
EDIT Editas Medicine | $1.31
-2.2% | 8/2/2023 | Target Lowered by | Chardan Capital | - | Buy -> Buy | $22.00 -> $19.00 | Low | View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 8/2/2023 |
NRGV Energy Vault | $1.69
+11.9% | 8/2/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $7.00 | Low | View details for Chardan Capital rating of Energy Vault (NYSE:NRGV) on 8/2/2023 |
LICY Li-Cycle | $1.48
+4.2% | 8/1/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $64.00 | Low | View details for Chardan Capital rating of Li-Cycle (NYSE:LICY) on 8/1/2023 |
BMTX BM Technologies | $4.80
+0.6% | 7/26/2023 | Target Lowered by | Chardan Capital | - | Buy | $13.00 -> $8.00 | Low | View details for Chardan Capital rating of BM Technologies (NYSE:BMTX) on 7/26/2023 |
KOD Kodiak Sciences | $8.65
-0.3% | 7/25/2023 | Downgraded by | Chardan Capital | Analyst D. Gataulin | Buy -> Neutral | | Low | View details for Chardan Capital rating of Kodiak Sciences (NASDAQ:KOD) on 7/25/2023 |
CLSK CleanSpark | $11.14
+2.1% | 7/24/2023 | Target Raised by | Chardan Capital | - | Buy | $6.00 -> $10.00 | Low | View details for Chardan Capital rating of CleanSpark (NASDAQ:CLSK) on 7/24/2023 |
FBRX Forte Biosciences | $19.34
+3.6% | 7/16/2023 | Reiterated by | Chardan Capital | Analyst K. Nakae | Neutral | | Low | View details for Chardan Capital rating of Forte Biosciences (NASDAQ:FBRX) on 7/16/2023 |
DFLI Dragonfly Energy | $3.12
+5.1% | 7/13/2023 | Reiterated by | Chardan Capital | - | Buy -> Buy | $90.00 | Low | View details for Chardan Capital rating of Dragonfly Energy (NASDAQ:DFLI) on 7/13/2023 |
OUST Ouster | $11.98
+15.0% | 7/13/2023 | Upgraded by | Chardan Capital | - | Neutral -> Buy | $10.00 | Low | View details for Chardan Capital rating of Ouster (NYSE:OUST) on 7/13/2023 |
WBX Wallbox | $0.53
+11.0% | 6/30/2023 | Target Lowered by | Chardan Capital | - | Buy | $12.00 -> $11.00 | Low | View details for Chardan Capital rating of Wallbox (NYSE:WBX) on 6/30/2023 |
ZURA Zura Bio | $2.28
-2.6% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 7/10/2023 |
XLO Xilio Therapeutics | $1.28
+36.5% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of Xilio Therapeutics (NASDAQ:XLO) on 7/10/2023 |
QURE uniQure | $16.98
+9.8% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 7/10/2023 |
IMVT Immunovant | $25.86
+0.8% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of Immunovant (NASDAQ:IMVT) on 7/10/2023 |
IMNM Immunome | $10.97
-1.0% | 7/10/2023 | Reiterated by | Chardan Capital | Analyst M. Barcus | Buy | | Low | View details for Chardan Capital rating of Immunome (NASDAQ:IMNM) on 7/10/2023 |
FDMT 4D Molecular Therapeutics | $6.31
+9.2% | 7/11/2023 | Target Raised by | Chardan Capital | - | | $30.00 -> $31.00 | Low | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/11/2023 |
FDMT 4D Molecular Therapeutics | $6.31
+9.2% | 7/5/2023 | Initiated by | Chardan Capital | - | Buy | $30.00 | Low | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/5/2023 |
ZURA Zura Bio | $2.28
-2.6% | 6/14/2023 | Initiated by | Chardan Capital | Analyst M. Barcus | Buy | $14.00 | Low | View details for Chardan Capital rating of Zura Bio (NASDAQ:ZURA) on 6/14/2023 |
